source
- Chinese biotech CEOs say US tensions won’t curb booming licensing dealsChinese biotech CEOs say they are not worried about rising US political tension and regulatory scrutiny. US lawmakers have increased scrutiny, referencing the America First Investment Policy and t…
- Sanofi to cut 229 Massachusetts jobs a year after $9.1 billion Blueprint Medicines acquisitionSanofi announced it will lay off 229 employees in Massachusetts, according to a filing with the state's Executive Office of Labor and Workforce Development. The workers are from Blueprint Medicine…